In a meeting held earlier this month with Niti Aayog, DoP also
suggested that trade margin on all formulations and dosages be capped
at 100%.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dop-lists-options-to-rationalise-drug-trade-margins-for-niti-aayog/articleshow/71344471.cms
No comments:
Post a Comment